Related Experiment Video
Updated: Aug 26, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway
Yingqiu Li1, Junru Hu, Randi Vita
1Division of Cell Biology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA.
Abstract:
Protein kinase C-theta (PKCtheta) plays an important role in T-cell activation via stimulation of AP-1 and NF-kappaB. Here we report the isolation of SPAK, a Ste20-related upstream mitogen-activated protein kinase (MAPK), as a PKCtheta-interacting kinase. SPAK interacted with PKCtheta (but not with PKCalpha) via its 99 COOH-terminal residues. TCR/CD28 costimulation enhanced this association and stimulated the catalytic activity of SPAK. Recombinant SPAK was phosphorylated on Ser-311 in its kinase domain by PKCtheta, but not by PKCalpha. The magnitude and duration of TCR/CD28-induced endogenous SPAK activation were markedly impaired in PKCtheta-deficient T cells. Transfected SPAK synergized with constitutively active PKCtheta to activate AP-1, but not NF-kappaB. This synergistic activity, as well as the receptor-induced SPAK activation, required the PKCtheta-interacting region of SPAK, and Ser-311 mutation greatly reduced these activities of SPAK. Conversely, a SPAK-specific RNAi or a dominant-negative SPAK mutant inhibited PKCtheta- and TCR/CD28-induced AP-1, but not NF-kappaB, activation. These results define SPAK as a substrate and target of PKCtheta in a TCR/CD28-induced signaling pathway leading selectively to AP-1 (but not NF-kappaB) activation.
Insights
We identified SPAK, a mitogen-activated protein kinase (MAPK), as a key activator of Protein kinase C-theta (PKCtheta) signaling in T cells. This interaction is crucial for T-cell activation and AP-1 stimulation.
Area of Science:
- Immunology
- Cell Signaling
- Molecular Biology
Background:
- Protein kinase C-theta (PKCtheta) is essential for T-cell activation, regulating transcription factors AP-1 and NF-kappaB.
- Understanding the upstream regulators of PKCtheta is critical for deciphering T-cell signaling pathways.
Purpose of the Study:
- To identify and characterize novel kinases that interact with and regulate PKCtheta.
- To elucidate the role of SPAK in PKCtheta-mediated T-cell activation.
Main Methods:
- Co-immunoprecipitation to identify interacting proteins.
- Kinase assays to measure catalytic activity.
- Site-directed mutagenesis to probe functional regions.
- RNA interference (RNAi) and dominant-negative mutants to assess functional roles.
- Western blotting to detect protein phosphorylation and activation.
Main Results:
- SPAK, a Ste20-related MAPK, was identified as a specific interactor of PKCtheta, binding to its C-terminus.
- T-cell receptor/CD28 costimulation enhanced SPAK-PKCtheta interaction and SPAK catalytic activity.
- PKCtheta directly phosphorylated SPAK at Ser-311, a critical event for SPAK activation.
- SPAK activation and subsequent AP-1 activation were significantly impaired in PKCtheta-deficient T cells.
- SPAK and PKCtheta synergistically activated AP-1, dependent on the SPAK-PKCtheta interaction region and Ser-311 phosphorylation.
Conclusions:
- SPAK is a novel substrate and direct target of PKCtheta in T-cell signaling.
- The SPAK-PKCtheta interaction is essential for TCR/CD28-induced T-cell activation, specifically promoting AP-1 transcription factor activity.
- This study defines a new signaling axis (PKCtheta-SPAK) crucial for adaptive immune responses.
Related Concept Videos
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

